Jin Ding

7.7k total citations
97 papers, 4.8k citations indexed

About

Jin Ding is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Jin Ding has authored 97 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 40 papers in Cancer Research and 18 papers in Hepatology. Recurrent topics in Jin Ding's work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (15 papers) and Liver physiology and pathology (14 papers). Jin Ding is often cited by papers focused on RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (15 papers) and Liver physiology and pathology (14 papers). Jin Ding collaborates with scholars based in China, United States and Hong Kong. Jin Ding's co-authors include Hongyang Wang, Beifang Ning, Wei‐Fen Xie, Wen Sun, Daimin Xiang, Zhuo Cheng, Tao Han, Cheng Chen, Gen‐Sheng Feng and Kun Wu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Jin Ding

92 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Ding China 40 3.0k 2.0k 1.0k 821 645 97 4.8k
Patricia Sancho Spain 33 2.5k 0.8× 1.3k 0.6× 1.4k 1.4× 362 0.4× 608 0.9× 61 4.0k
Wei‐Fen Xie China 38 2.1k 0.7× 999 0.5× 905 0.9× 1.2k 1.5× 355 0.6× 116 4.3k
Elizabeth A. Conner United States 34 2.5k 0.8× 927 0.5× 1.0k 1.0× 1.5k 1.8× 282 0.4× 46 4.4k
Hayato Hikita Japan 29 1.7k 0.6× 723 0.4× 600 0.6× 842 1.0× 492 0.8× 133 3.6k
George G. Chen Hong Kong 31 2.2k 0.7× 1.1k 0.5× 862 0.8× 293 0.4× 397 0.6× 119 3.6k
Yexiong Tan China 35 2.3k 0.8× 1.1k 0.5× 627 0.6× 252 0.3× 347 0.5× 77 3.5k
Junji Matsui Japan 31 2.0k 0.7× 842 0.4× 1.8k 1.7× 826 1.0× 427 0.7× 91 5.7k
Maen Abdelrahim United States 40 2.7k 0.9× 1.0k 0.5× 1.3k 1.2× 218 0.3× 621 1.0× 157 5.2k
Antonio Mazzocca Italy 30 1.4k 0.5× 691 0.3× 815 0.8× 768 0.9× 343 0.5× 86 3.0k
Stephanie Ma Hong Kong 47 5.0k 1.7× 3.0k 1.5× 3.9k 3.8× 1.4k 1.7× 940 1.5× 125 8.8k

Countries citing papers authored by Jin Ding

Since Specialization
Citations

This map shows the geographic impact of Jin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Ding more than expected).

Fields of papers citing papers by Jin Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Ding. The network helps show where Jin Ding may publish in the future.

Co-authorship network of co-authors of Jin Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Ding. A scholar is included among the top collaborators of Jin Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Ding. Jin Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ding, Jin, et al.. (2024). A Blockchain Network Admission Control Mechanism Using Anonymous Identity-Based Cryptography. Applied Sciences. 15(1). 130–130.
3.
Ji, Linlin, et al.. (2024). Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms. Cancer Communications. 45(1). 15–42. 18 indexed citations
4.
Shao, Zhiying, Wendong Yang, Hui Qiu, et al.. (2024). The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis. Cell Death and Disease. 15(5). 347–347. 8 indexed citations
5.
Su, Chang, et al.. (2023). Prognostic value of Ki-67 in patients with ovarian cancer. European Journal of Gynaecological Oncology. 1 indexed citations
6.
Ding, Jin, et al.. (2023). Guilu Erxian glue mitigates oxidative damage in mouse GC-1 spermatogonial cells by inhibiting autophagy via the Keap1/Nrf2 pathway. Journal of Traditional Chinese Medical Sciences. 10(4). 484–492. 1 indexed citations
7.
Ding, Jin, Yan Chen, Zhiguo Xie, et al.. (2023). Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals. Journal of Diabetes Investigation. 15(1). 34–43. 3 indexed citations
8.
Li, Qin, et al.. (2023). MALAT1 modulates trophoblast phenotype via miR-101–3p/VEGFA axis. Archives of Biochemistry and Biophysics. 744. 109692–109692. 8 indexed citations
9.
Liu, Junyu, et al.. (2023). Expression pattern of PD‐1/PD‐L1 in primary liver cancer with clinical correlation. Liver International. 43(9). 1995–2001. 4 indexed citations
10.
Zhou, Lei, Martina Mang Leng Lei, Hoi-Wing Leung, et al.. (2022). Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma. Cancer Research. 82(17). 3102–3115. 71 indexed citations
11.
Sun, Wen, Shichao Li, Li Xu, et al.. (2020). High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma. Clinical Cancer Research. 26(16). 4302–4312. 16 indexed citations
12.
Zhou, Tengfei, Shichao Li, Daimin Xiang, et al.. (2020). m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduction and Targeted Therapy. 5(1). 296–296. 100 indexed citations
13.
Leung, Carmen Oi Ning, Man Tong, Noélia Che, et al.. (2019). Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma. Hepatology. 72(1). 155–168. 73 indexed citations
14.
Xu, Wenping, Jinpei Liu, Jifeng Feng, et al.. (2019). miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 69(7). 1309–1321. 88 indexed citations
15.
16.
Wen, Liangzhi, Kai Ding, Ze-Rui Wang, et al.. (2018). SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression. Cancer Research. 78(16). 4680–4691. 68 indexed citations
17.
Xiang, Daimin, Wen Sun, Beifang Ning, et al.. (2017). The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 67(9). 1704–1715. 181 indexed citations
18.
Li, Xiaofeng, Cheng Chen, Daimin Xiang, et al.. (2017). Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66(6). 1934–1951. 104 indexed citations
19.
Wen, Wen, Jin Ding, Wen Sun, et al.. (2010). Suppression of Cyclin D1 by Hypoxia-Inducible Factor-1 via Direct Mechanism Inhibits the Proliferation and 5-Fluorouracil–Induced Apoptosis of A549 Cells. Cancer Research. 70(5). 2010–2019. 69 indexed citations
20.
Ning, Beifang, Jin Ding, Chuan Yin, et al.. (2010). Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma. Cancer Research. 70(19). 7640–7651. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Sancho Breakdown of academic impact, for papers by Wei‐Fen Xie Breakdown of academic impact, for papers by Elizabeth A. Conner Breakdown of academic impact, for papers by Hayato Hikita Breakdown of academic impact, for papers by George G. Chen Breakdown of academic impact, for papers by Yexiong Tan Breakdown of academic impact, for papers by Junji Matsui Breakdown of academic impact, for papers by Maen Abdelrahim Breakdown of academic impact, for papers by Antonio Mazzocca Breakdown of academic impact, for papers by Stephanie Ma
Rankless by CCL
2026